Hereditary Angioedema

Published date: 9 February 2022

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.

Closing: 16 March 2022, 1pm

Contract summary

Industry

Blood products - 33141510
Plasma extracts - 33141520
Pharmaceutical products - 33600000

Location of contract

Channel Islands, United Kingdom, Isle of Man

Value of contract

£74,500,000

Procurement reference

CF-0624500D0O000000rwimUAA1

Published date

9 February 2022

Closing date

16 March 2022

Closing time

1pm

Contract start date

1 July 2022

Contract end date

31 December 2023

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Description

NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. The framework will commence on 1 July 2022 for a period of 18 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be nor more than 48 months. Please refer to the offer documents for the list of purchasing points.

More information

Links

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HHKo/K8z1uAKnpodQ6lf2d9RiTkbLjJYLSIVFY.oLrlD9y0Y
Document No. 05a - Offer Schedule

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HHLr/TguYZ0JDudQ3wbO0wGtzs5yU1NQU.jkEppiJbb6mEds
FTS Notice - S003602-2022

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HHKc/i3h1mJIFROXDZujoYRxFrDtutdHfS3Vx9NsgKmqFgm0
Document No. 01 - Invitation to offer covering letter (vA3902789)

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HHKh/keJR8qhKsrmBF.5LqDsiBXEc2aICHhYI_1xOIzAUY_o
Document No. 02 - Terms of offer

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HHKd/SlfQhao_jeXUMDfwzQquH_vS0HJamCV4V4RLbSEtl4M
Document No. 03 - Framework Agreement and Terms and Conditions

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HHKi/YbNkMsX92ZuhFRiai0vLtFolvovfvE.Cy3nommmQU9M
Document No. 04a - Contract Specifics

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HHL2/Zeys0jNjw2rHksT8ZmBfZ6ssg198hQCzEyrWp.zuK1U
Document No. 07a - Quality control technical sheet (vA3915194)

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HHKm/YDWoO7CGfebaOUwzQItnAsP8z9xwOTCfRGC4kyi8kH8
Document No. 04b - Management information schedule

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HHKw/F0J.vT0aTdCH8EpmTXauXxtP5PGv8lUizZoUnmkZ5AA
Document No. 04d - Participating Authorities

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HHKp/7Ev5CUiTOpu7nt0QyXKuv4sCACHcD_jQKhUtFUF7bzQ
Document No. 05b - Scoring Methodology

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HHL1/syXj.s3GrZajhaX7aqXGyRLDEU25lx6_z0NgAm1RZT4
Document No. 06 - Form of offer

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HHKn/h3Ol4ERUAYrLrxX4GppTJ61Nl3VgawegEBs7fq75iNY
Document No. 04c - Supplier Management Information Schedule

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HHLp/rqd2SZ_DWe9P4Sv1cWdCxAGSM7qXRioo2F2UkLay08Q
Document No. 07b - Guidance for performing a risk assessment of licensed medicines for the NHS (vA3902800)

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HHLq/nMHMv7ObJprgZWpdmEKaDunITEgO0nzs3CrLUiSNsuI
Document No. 08 - Confidential information schedule

About the buyer

Contact name

Philip Grieve

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
GB

Email

philip.grieve@nhs.net